Abstract
A simple, precise, reliable, rapid and reproducible reversed-phase high performance liquid chromatographic method (RP-HPLC) method has was developed and validated for the estimation of Nintedanib Esylate. Chromatography was carried out with analytical technology. HPLC system consisted of UV-3000-M detector on C18 (4.6×250 mm, 5 μ) column with a mobile phase composed of methanol:water (80:20 v/v) at a flow rate of 1 ml/min. The pH of the mobile phase was adjusted by 0.05% ortho phosphoric acid (pH-3). Detection was carried out using a UV detector at 287 nm. Parameters such as linearity, precision, accuracy, ruggedness, robustness, LOD and LOQ were studied as per the ICH Q2 (R1) guidelines. The retention time was found to be 4.67 min. The linearity range for Nintedanib esylate was 10–60 μg/ml. The correlation coefficient was found to be 0.999. Developed method was found to be accurate, precise, selective and rapid for estimation of Nintedanib esylate in pharmaceutical dosage form. The proposed method can be useful in quality control of bulk manufacturing and pharmaceutical dosage form. Keywords: ICH guidelines, method validation, Nintedanib esylate, RP-HPLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
